14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
An IT consulting company based in Southern California recently paid $48,193 to one employee after th...
Read More >
I just blogged about asking for what you want and the importance of complying with notice provisions...
Read More >
After more than two years without one, three ERISA cases will come before the US Supreme Court in 20...
Read More >
Every player interested or already active in the German market needs to have a working knowledge of ...
Read More >
Under the U.S. Sentencing Guidelines, the Board must exercise reasonable oversight on the effectiven...
Read More >
Primary HSR filing threshold will be raised to $94 million - The Federal Trade Commission has anno...
Read More >